WISP-3 functions as a ligand and promotes superoxide dismutase activity
- 1 March 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (1) , 259-265
- https://doi.org/10.1016/j.bbrc.2006.01.132
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Wnt‐1–inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritisArthritis & Rheumatism, 2005
- Molecular study of WISP3 in nine families originating from the Middle‐East and presenting with progressive pseudorheumatoid dysplasia: Identification of two novel mutations, and description of a founder effectAmerican Journal of Medical Genetics Part A, 2005
- Vulnerability to ROS-induced cell death in ageing articular cartilage: The role of antioxidant enzyme activityOsteoarthritis and Cartilage, 2005
- CCN workshopJournal of Clinical Pathology, 2005
- WISP3‐dependent regulation of type II collagen and aggrecan production in chondrocytesArthritis & Rheumatism, 2004
- Role of CTGF/HCS24/ecogenin in skeletal growth controlJournal of Cellular Physiology, 2003
- WISP-1 Binds to Decorin and BiglycanJournal of Biological Chemistry, 2001
- Connective Tissue Growth Factor: What's in a Name?Molecular Genetics and Metabolism, 2000
- Temporal Expression of the Chondrogenic and Angiogenic Growth Factor CYR61 During Fracture RepairJournal of Bone and Mineral Research, 2000
- Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.Journal of Clinical Investigation, 1994